Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

101. Cross-reactions of H7 subtype influenza vaccines: a systematic review and meta-analysis

Cross-reactions of H7 subtype influenza vaccines: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO

102. Influenza infection

Influenza infection Influenza infection - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Influenza infection Last reviewed: February 2019 Last updated: March 2019 Summary Characterised by upper and lower respiratory tract symptoms of rhinorrhoea, cough, fever, chills, headache, and myalgia. Typically presents in winter season. Can occur in local community outbreaks, epidemics, and, rarely, pandemics. Vaccination (...) for prevention is available. Definition Acute respiratory tract infection typically caused by seasonal influenza A or B virus. The virus is transmitted by inhalation of infected respiratory secretions that have been aerosolised through coughing, sneezing, or talking. Brankston G, Gitterman L, Hirji Z, et al. Transmission of influenza A in human beings. Lancet Infect Dis. 2007;7:257-265. http://www.ncbi.nlm.nih.gov/pubmed/17376383?tool=bestpractice.com History and exam winter season current influenza outbreak

2018 BMJ Best Practice

103. Psychological factors associated with seasonal influenza vaccination uptake among adults with a high-risk physical health condition: a systematic review

Psychological factors associated with seasonal influenza vaccination uptake among adults with a high-risk physical health condition: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

104. Safety and immunogenicity of seasonal influenza vaccines during pregnancy: a systematic review

Safety and immunogenicity of seasonal influenza vaccines during pregnancy: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

105. Avian influenza A (H7N9) virus infection

Avian influenza A (H7N9) virus infection Avian influenza A (H7N9) virus infection - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Avian influenza A (H7N9) virus infection Last reviewed: February 2019 Last updated: June 2018 Summary The epidemic has been geographically focused in China, and is associated with exposure to infected poultry. The risk to public health is low; however, the pandemic potential of this virus (...) of respiratory tract samples is the recommended diagnostic test. Treatment involves supportive care, specialised intensive-care management, and administration of a neuraminidase inhibitor. Definition Avian influenza A viruses are generally confined to birds but have infected other mammals and some viruses have crossed the species barrier to sporadically infect humans. Highly pathogenic avian influenza (HPAI) A(H5N1) virus is capable of causing severe multi-system disease in birds, humans, and other mammals

2018 BMJ Best Practice

106. Is there a difference in the immune response, efficacy, and safety of seasonal influenza vaccine in males and females? A meta-analysis protocol

Is there a difference in the immune response, efficacy, and safety of seasonal influenza vaccine in males and females? A meta-analysis protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

107. Systematic review of antivirals use for hospitalized adults with influenza

Systematic review of antivirals use for hospitalized adults with influenza Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2018 PROSPERO

108. An evaluation of influenza surveillance systems in sub-Saharan Africa: a systematic review

An evaluation of influenza surveillance systems in sub-Saharan Africa: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

109. Global patterns in seasonal activity of influenza (IFV), respiratory syncytial virus (RSV), parainfluenza virus (PIV), metapneumovirus (MPV) and all-cause acute lower respiratory infection (ALRI): a systematic review

Global patterns in seasonal activity of influenza (IFV), respiratory syncytial virus (RSV), parainfluenza virus (PIV), metapneumovirus (MPV) and all-cause acute lower respiratory infection (ALRI): a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated

2018 PROSPERO

110. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in older adults compared to adults: a systematic review and meta-analysis

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in older adults compared to adults: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

111. A systematic review on strategies for increasing vaccination rates against influenza in patients with chronic diseases in primary care

A systematic review on strategies for increasing vaccination rates against influenza in patients with chronic diseases in primary care Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

112. Influenza vaccination for heart failure patients systematic review

Influenza vaccination for heart failure patients systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2018 PROSPERO

113. Herbal medicine treatment for influenza: a systematic review and meta-analysis of randomized controlled trials

Herbal medicine treatment for influenza: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

114. The role of corticosteroids in the mortality of patients with influenza pneumonia: a systematic review and meta analysis

The role of corticosteroids in the mortality of patients with influenza pneumonia: a systematic review and meta analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

115. Influenza

Influenza Influenza - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Influenza Note: Prescribing of oral antiviral agents is authorized ONLY during an epidemic or pandemic declared by the Chief Medical Health Officer for Saskatchewan Influenza is an acute viral respiratory tract infection caused by influenza A or B viruses (family Orthomyxoviridae ) Influenza-like illness (ILI) refers to any acute illness having symptoms (...) typical of influenza. Viruses such as adenovirus, parainfluenza or respiratory syncytial virus can cause similar symptoms Influenza causes outbreaks and epidemics worldwide, primarily during the late fall and winter Transmission of the Influenza virus may occur via airborne droplets or by contact or both. Symptoms can be quite incapacitating but for most people influenza is a self-limited infection and resolves without treatment in 4 to 7 days Affects an estimated 10% to 20% of the Canadian population

2018 medSask

116. Accuracy and Discomfort of Different Types of Intranasal Specimen Collection Methods for Molecular Influenza Testing in Emergency Department Patients (Abstract)

Accuracy and Discomfort of Different Types of Intranasal Specimen Collection Methods for Molecular Influenza Testing in Emergency Department Patients While development is under way of accurate, point-of-care molecular tests for influenza infection, the optimal specimen type for molecular tests remains unclear. Compared with standard nasopharyngeal swab specimens, less invasive nasal swab and midturbinate swab specimens may cause less patient discomfort and be more suitable for routine emergency (...) department (ED) testing, although possibly at the expense of diagnostic accuracy. We compare both the accuracy of a polymerase chain reaction molecular influenza test and discomfort between these 3 intranasal specimen types.A convenience sample of adult and pediatric patients with influenza-like illness and presenting to 2 Northern California EDs and 2 EDs in Santiago, Chile, was prospectively enrolled during the 2015 to 2016 influenza season. Research nurses collected nasopharyngeal swab, midturbinate

2018 EvidenceUpdates

117. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Full Text available with Trip Pro

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Estimates of influenza-associated mortality are important for national and international decision making on public health priorities. Previous estimates of 250 000-500 000 annual influenza deaths are outdated. We updated the estimated number of global annual influenza-associated respiratory deaths using country-specific influenza-associated excess respiratory mortality estimates from 1999-2015.We (...) estimated country-specific influenza-associated respiratory excess mortality rates (EMR) for 33 countries using time series log-linear regression models with vital death records and influenza surveillance data. To extrapolate estimates to countries without data, we divided countries into three analytic divisions for three age groups (<65 years, 65-74 years, and ≥75 years) using WHO Global Health Estimate (GHE) respiratory infection mortality rates. We calculated mortality rate ratios (MRR) to account

2017 Lancet

118. Integrative gene network analysis identifies key signatures, intrinsic networks and host factors for influenza virus A infections Full Text available with Trip Pro

Integrative gene network analysis identifies key signatures, intrinsic networks and host factors for influenza virus A infections Influenza A virus, with the limited coding capacity of 10-14 proteins, requires the host cellular machinery for many aspects of its life cycle. Knowledge of these host cell requirements not only reveals molecular pathways exploited by the virus or triggered by the immune system, but also provides further targets for antiviral drug development. To uncover novel (...) pathways and key targets of influenza infection, we assembled a large amount of data from 12 cell-based gene-expression studies of influenza infection for an integrative network analysis. We systematically identified differentially expressed genes and gene co-expression networks induced by influenza infection. We revealed the dedicator of cytokinesis 5 (DOCK5) played potentially an important role for influenza virus replication. CRISPR/Cas9 knockout of DOCK5 reduced influenza virus replication

2017 NPJ systems biology and applications

119. Real-time modelling of a pandemic influenza outbreak

Real-time modelling of a pandemic influenza outbreak Real-time modelling of a pandemic influenza outbreak Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline

2017 NIHR HTA programme

120. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness –Virus grippaux zoonotiques: caractéristiques génétiques et antigéniques et mise au point de virus vaccinaux candidat

Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness –Virus grippaux zoonotiques: caractéristiques génétiques et antigéniques et mise au point de virus vaccinaux candidat Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness –Virus grippaux zoonotiques: caractéristiques génétiques et antigéniques et mise au point de virus (...) vaccinaux candidats pour se préparer à une pandémie JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness –Virus grippaux zoonotiques: caractéristiques génétiques et antigéniques et mise au point de virus vaccinaux candidats pour se préparer à une pandémie

2017 WHO